# Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period.

> **NCT07223060** · PHASE2,PHASE3 · COMPLETED · sponsor: **Colgate Palmolive** · enrollment: 100 (actual)

## Conditions studied

- Calculus, Dental

## Interventions

- **DRUG:** 0.454% stannous fluoride
- **DRUG:** 0.76% sodium monofluorophosphate

## Key facts

- **NCT ID:** NCT07223060
- **Lead sponsor:** Colgate Palmolive
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2017-10-06
- **Final completion:** 2017-10-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07223060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07223060, "Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07223060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*